Intrexon dna.com


Public lists: Synthetic Biology (133)

Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA to create biologically-based products that improve the quality of life and the health of the planet. The Company's integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.

Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA to create biologically-based products that improve the quality of life and the health of the planet. The Company's integrated technology suite provides its part...Show all

Company (IPO / Went public)

Phone:

Fax:

20358 Seneca Meadow Parkway

Germantown, 20876
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Intrexon $669M Aug 8, 2013
CELLZDIRECT $0M Jan 7, 2008
NanoBioNexus $0M May 18, 2017
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Intrexon Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Endoplasmic reticulum localization signals Sep 11, 2015 Apr 11, 2017 Patent
Methods and compositions for diagnosing disease Nov 23, 2015 Mar 28, 2017 Patent
Crystalline diacylhydrazine and the use thereof Oct 21, 2014 Mar 28, 2017 Patent
Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex Oct 09, 2014 Mar 21, 2017 Patent
Cryoprotectants for freeze drying of lactic acid bacteria Apr 28, 2010 Feb 21, 2017 Patent
See all 128 patents